James P. Kelly

2014 - Vanda Pharmaceuticals

In 2014, James P. Kelly earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,000
Option Awards$421,200
Salary$360,000
Stock Awards$245,400
Other$19,611
Total$1,226,211

Kelly received $421.2K in option awards, accounting for 34% of the total pay in 2014.

Kelly also received $180K in non-equity incentive plan, $360K in salary, $245.4K in stock awards and $19.6K in other compensation.

Rankings

In 2014, James P. Kelly's compensation ranked 6,669th out of 13,032 executives tracked by ExecPay. In other words, Kelly earned more than 48.8% of executives.

ClassificationRankingPercentile
All
6,669
out of 13,032
49th
Division
Manufacturing
2,442
out of 4,966
51st
Major group
Chemicals And Allied Products
822
out of 1,686
51st
Industry group
Drugs
645
out of 1,365
53rd
Industry
Pharmaceutical Preparations
492
out of 1,043
53rd
Source: SEC filing on April 27, 2017.

Kelly's colleagues

We found two more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2014.

2014

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2014

Paolo Baroldi

Vanda Pharmaceuticals

Chief Medical Officer

News

You may also like